Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter 2 Inhibitor Prescriptions in Type 2 Diabetes by Kidney and Cardiovascular Disease
Journal of the American Society of Nephrology · 2025-02 · 36 (2) · 290-292
DOI: 10.1681/asn.0000000585 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, online erschienen am 27.11.2024. Verfasst von Sneha S Mehta und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, NYU Grossman School of Medicine, New York, New York. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Medicine, NYU Grossman School of Medicine, New York, New York.
- Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
- Center for Healthcare Innovation and Delivery Science, NYU Langone Health, Departments of Population Health and Medicine, NYU Grossman School of Medicine, New York, New York.
- Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
- Departments of Nephrology and Population Health Sciences, Geisinger Health, Danville, Pennsylvania.
- Departments of Medicine and Population Health NYU Grossman School of Medicine, New York, New York.
ORCID-Profile: Aditya L Surapaneni, Yunwen Xu, Leora Horwitz, Matthew F Blum, Alexander R Chang, Jung-Im Shin, Morgan E Grams
Förderung
- NIDDK NIH HHS
- NHLBI NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Mehta, S. S., Surapaneni, A. L., Pandit, K., Xu, Y., Horwitz, L., Blecker, S., Blum, M. F., Chang, A. R., Shin, J. I., & Grams, M. E. (2025). Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter 2 Inhibitor Prescriptions in Type 2 Diabetes by Kidney and Cardiovascular Disease. Journal of the American Society of Nephrology, 36(2), 290-292. https://doi.org/10.1681/asn.0000000585
Vancouver
Mehta SS, Surapaneni AL, Pandit K, Xu Y, Horwitz L, Blecker S, et al. Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter 2 Inhibitor Prescriptions in Type 2 Diabetes by Kidney and Cardiovascular Disease. Journal of the American Society of Nephrology. 2025;36(2):290-292. doi:10.1681/asn.0000000585
BibTeX
@article{Mehta2025,
author = {Mehta, Sneha S and Surapaneni, Aditya L and Pandit, Krutika and Xu, Yunwen and Horwitz, Leora and Blecker, Saul and Blum, Matthew F and Chang, Alexander R and Shin, Jung-Im and Grams, Morgan E},
title = {Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter 2 Inhibitor Prescriptions in Type 2 Diabetes by Kidney and Cardiovascular Disease},
journal = {Journal of the American Society of Nephrology},
year = {2025},
volume = {36},
number = {2},
pages = {290--292},
doi = {10.1681/asn.0000000585}
}
EUVIMED